Y, O., T, K., A, I., K, T., Y, S., YS, K., . . . T, S. (2018). Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness. Dove Medical Press.
Chicago Style (17th ed.) CitationY, Omori, et al. Orexin/hypocretin Levels in the Cerebrospinal Fluid and Characteristics of Patients with Myotonic Dystrophy Type 1 with Excessive Daytime Sleepiness. Dove Medical Press, 2018.
MLA (8th ed.) CitationY, Omori, et al. Orexin/hypocretin Levels in the Cerebrospinal Fluid and Characteristics of Patients with Myotonic Dystrophy Type 1 with Excessive Daytime Sleepiness. Dove Medical Press, 2018.
Warning: These citations may not always be 100% accurate.